C1408354||non-breast cancer-specific death
C0006142||breast cancer
C1408354||non-breast cancer-specific death
C1408354||non-breast cancer-specific death
C0006142||breast cancer
C0043210||Women
C0006142||breast cancer
C0242638||Surveillance, Epidemiology, and End Results database
C0936012||analyzed
C0006142||breast cancer
C1408354||non-breast cancer-specific death
C0206031||Binary logistics
C1408354||non-breast cancer-specific death
C0282574||Gray method
C1408354||non-breast cancer-specific death
C1408354||non-BCSDs
C0007465||causes of death
C3272897||stacked
C0681493||function plots
C1408354||non-breast cancer-specific death
C0010235||Models of Cox proportional hazards regression
C0034980||competing risk regression
C3161035||suitable model
C1408354||non-BCSDs
C0005680||black race
C1408354||non-BCSDs
C1562029||hormone receptor-positive (HoR+) status
C1408354||non-breast cancer-specific death
C0012634||grade 1, stage I disease
C1562029||HoR+ status
C1408354||non-breast cancer-specific death
C0007465||causes of death
C0010235||Cox proportional hazards model
C0034980||competing risk model
C1408354||non-breast cancer-specific death
C0006142||breast cancer
C0008976||clinical trial
C1562029||hormone receptor-positive
C0006142||breast cancer
C1408354||non-breast cancer-specific death
C0002455||American Cancer Society